Project ideas from Hacker News discussions.

Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s

📝 Discussion Summary (Click to expand)

Generating summary…


🚀 Project Ideas

Human‑First Medical Copy Review Service

Summary

  • Provides on‑demand human copy review and rewrite for health‑tech websites, eliminating AI‑generated “slop” and ensuring clear, compliant messaging.
  • Core value: builds trust with patients and regulators by delivering medically accurate, human‑toned copy that converts.

Details

Key Value
Target Audience Early‑stage health‑tech startups, telehealth providers, compounding pharmacies needing website/landing‑page copy.
Core Feature Human copywriter team (with medical background) edits AI drafts or writes from scratch, includes compliance check (FDA/FTC language) and quick turnaround (<48 h).
Tech Stack Web portal (React/NestJS), Stripe for payments, optional AI‑assisted first draft (LLM) + human editor queue, hosted on Vercel/AWS.
Difficulty Medium
Monetization Revenue-ready: subscription tier ($99/mo for up to 5 pages) or pay‑per‑page ($30/page).

Notes

  • HNers complained about “Claude‑ish” copy and wanted a human rewrite (didgeoridoo, lloydarmbrust). This service directly addresses that pain.
  • Could spark discussion on balancing AI efficiency with human trust in medical messaging; practical utility for improving conversion and reducing compliance risk.

Personalized GLP‑1 Titration & Feedback App

Summary

  • Mobile/web app lets patients on GLP‑1 therapies log daily symptoms, side effects, weight, and blood‑work results, then sends structured dose‑adjustment requests to their clinician for approval.
  • Core value: closes the feedback loop missing in current telehealth GLP services, enabling safe, personalized dose titration without rigid, one‑size‑fits‑all schedules.

Details

Key Value
Target Audience Patients using semaglutide, tirzepatide, or other GLP‑1 agonists; clinicians who prescribe them.
Core Feature Symptom & outcome tracker, automated titration suggestions based on simple rules (e.g., increase if tolerance, decrease if GI side effects), secure messaging to doctor for approval, integrates with EHR via FHIR.
Tech Stack React Native (mobile) + Node.js/Express backend, PostgreSQL, Auth0 for auth, Twilio for notifications, optional HL7/FHIR server.
Difficulty Medium
Monetization Revenue-ready: B2B SaaS for clinics ($150/clinic/mo) + optional patient premium ($4.99/mo).

Notes

  • Commenters lamented inflexible telehealth processes and difficulty adjusting dose (colingauvin, anonymous391084). An app that lets patients request dose changes based on how they feel would be welcomed.
  • Enables richer discussion on patient‑driven dosing, safety, and could become a foundation for outcomes‑based reimbursement models.

Compound Pharmacy Operations SaaS for MSOs

Summary

  • A SaaS platform that coordinates prescriptions, inventory, and batch tracking between medical service organizations (MSOs) and compounding pharmacies, handling BAA/HIPAA docs, batch manifests, and regulatory compliance.
  • Core value: reduces manual paperwork, ensures transparent, personalized compounding, and lets MSOs scale safely while maintaining control over the supply chain.

Details

Key Value
Target Audience MSOs, telehealth brands, and compounding pharmacies that produce personalized GLP‑1, peptides, or HRT formulations.
Core Feature Prescription routing portal, real‑time batch status (API → compounding → fill‑finish → shipment), automated BAA/HIPAA document management, compliance checklist (USP <795>, state pharmacy board), analytics on yield and turnaround time.
Tech Stack Django (Python) + React UI, Postgres, Redis for queue, AWS S3 for document storage, DocuSign API for signatures, webhook telephony for SMS updates.
Difficulty High
Monetization Revenue-ready: tiered subscription ($500/mo base + $0.10 per prescription processed) or per‑batch fee.

Notes

  • HN users discussed credit‑card processing being solved via Stripe but highlighted complexity of legal front, manufacturing, and needing a “glue” that’s not hard (rootsudo). This SaaS provides that glue.
  • Would generate practical utility by simplifying the MSO‑pharmacy workflow, potentially becoming a discussion point for scaling personalized meds while staying compliant.

Read Later